India pharma market expected to hit USD 130 bn by 2030: Commerce Secretary

Day 1 conference highlights include news from Moderna, BridgeBio

DRRA15 hours ago 0

FDA again rejects tabelecleucel for EBV-driven post-transplant lymphoproliferative disease

DRRA16 hours ago 0

New data, nuances in managing resistant gram-negative infections

DRRA17 hours ago 0

New Year’s resolutions 2026: Lessons from colleagues

DRRA17 hours ago 0